MillicomTigo-azul-transparente.png
Millicom (Tigo) share repurchase activity
March 28, 2024 17:30 ET | Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, March 28, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 23,831 of its Swedish Depository...
POAI New LOGO.jpg
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
March 28, 2024 17:28 ET | Predictive Oncology Inc.
PITTSBURGH, March 28, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science driven company leveraging its proprietary artificial intelligence and machine learning capabilities,...
LOGO-01.png
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 17:16 ET | Burning Rock Biotech Limited
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
wintrust-out-2color-rgb.png
Wintrust Wins Highest Ranking by J.D. Power for Illinois Retail Banking Customer Satisfaction for the Third Year in a Row
March 28, 2024 17:05 ET | Wintrust Financial Corporation
ROSEMONT, Ill., March 28, 2024 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation (Nasdaq:WTFC) today announced that Wintrust Community Banks received the award for ranking highest in the J.D. Power...
Crossfirst_Bankshare_LeftJustifiedStacked_Logo.jpg
CrossFirst Bankshares, Inc. To Host First Quarter 2024 Earnings Call
March 28, 2024 17:05 ET | CrossFirst Bankshares, Inc.
CrossFirst Bankshares, Inc. To Host First Quarter 2024 Earnings Call
aim.jpg
Aimfinity Investment Corp. I Announces Eighth Extension of the Deadline for an Initial Business Combination to April 28, 2024
March 28, 2024 17:00 ET | Aimfinity Investment Corp. I
Wilmington, Delaware, , March 28, 2024 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “Company” or “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman...
Verve-Logo-RGB-Color-wTrademark.png
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024 16:51 ET | Verve Therapeutics
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing...
logo_500x500.png
Bitdeer Reports Financial Results for the Full Year 2023 and Operational Update
March 28, 2024 16:45 ET | Bitdeer Technologies Group
SINGAPORE, March 29, 2024 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world-leading technology company for blockchain and high-performance...
TMT Acquisition Corp Announces Adjournment of Extraordinary General Meeting
March 28, 2024 16:44 ET | TMT Acquisition Corp
New York, New York, March 28, 2024 (GLOBE NEWSWIRE) -- TMT Acquisition Corp (Nasdaq: TMTCU, TMTC, and TMTCR) (the “Company”) announced today that the extraordinary general meeting originally...
zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
March 28, 2024 16:32 ET | Zevra Therapeutics
Launch of OLPRUVA® underway Topline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH symptoms Q4 2023 net revenue of $13.2M, and FY 2023 net revenue of $27.5M ...